SOURCE: Unliava Corporation

May 31, 2011 09:00 ET

Unilava Announces New Advisory Board Member

SAN FRANCISCO, CA--(Marketwire - May 31, 2011) - Unilava Corporation (OTCBB: UNLA), a leading provider of communication products and services to both business and residential customers, today announced Ahmad Moradi, PhD as a new member to the Advisory Board, originally formed and announced in February 2010. Comprised of established leaders in the interactive telecommunications industry with broad, multi-disciplinary backgrounds, the Advisory Board provides continued guidance and counsel to support the company's growth strategy, developing innovative technology and ensure alignment and execution of business objectives.

Baldwin Yung, President and CEO of Unilava Corporation, comments, "We are thrilled to have Mr. Ahmad Moradi join our Advisory Board. He has over 20 years of experience in the interactive media field and I am very optimistic that he will bring tremendous value to our company by providing insight and knowledge in social and media networking as we reshape our future revenue growth."

Ahmad Moradi, Ph.D. has served as Chief Executive Officer and President of Interchange Medical Inc. since April 1999. Dr. Moradi has been Chief Executive Officer of Biomed Research Technologies Inc. since September 1997. He also serves as Chairman and Chief Executive Officer of Netstairs.com Inc. and Maxwell Rand Inc., two development stage companies. He serves as Computer Service Engineer of Globe Staff Consulting Corporation. Dr. Moradi has been a consultant specializing in high technology management information engineering systems for the past fourteen (14) years. Dr. Moradi has been inducted in over 35 Who's Who Registries Worldwide. He served as the Chief Executive Officer of Savenergy Holdings, Inc., since August 1998. Dr. Moradi served as Chairman and Chief Executive Officer of Andorra Capital Corp. from August 1998 to July 2000. Since 1992, he served as President of g4, Inc., an information systems and business strategy consulting firm. He has 20 years of experience in information technology, communications, software development, marketing, business management, mergers, acquisitions and managing public corporations. He serves as Chairman of Biomed Research Technologies, Inc. Dr. Moradi serves as Chairman of Interchange Medical Inc. and has also been its Director since April 1999. He has been a Director of Andorra Capital Corp. (formerly Worldcast Interactive Inc.) since August 1998. He serves as Director of Dunhil-Medinet-Worldwide, Inc. He has been a Director of Savenergy Holdings, Inc., since August 1998. He serves as Director of American Surgery Centers Corp. Dr. Moradi serves as Computer Service Engineer and Member of Executive Utility Committee of Power Source Corp. Dr. Moradi holds a B.S. and M.A. degrees in the fields of mathematics, engineering and international business from Florida Atlantic University in 1989. He received a Ph.D. in management information systems from LaSalle University.

About Unilava Corporation
Unilava Corporation and its subsidiary brands provide a variety of communications services, products, and equipment that address the needs of small to enterprise businesses and consumers. The company is licensed to provide interactive, long distance services in 41 States and local phone services in 11 States. Through its carrier-grade microwave wireless broadband infrastructure and broadband Internet access partners, the company offers mobile and high-definition IP-hosted voice services to residential, small and medium enterprises. The company delivers small business a comprehensive and integrated suite of fee-based online and mobile advertising and web services. Headquartered in San Francisco, the company has regional offices in Chicago, Fort Lauderdale, Seoul, Hong Kong, and Beijing. For more information, please visit www.unilava.com.

This News Release may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove correct.

Contact Information

  • Press /Analyst Contact:
    Investor Relations
    415.321.3490
    Email Contact